Abstract:The recovery of the virus from genetic materials in in vitro culture systems or sensitive animals is called virus rescue. A functional infectious clone of RNA virus provides unlimited possibility for genetic studies and the related reverse genetics system that allows directed genetic manipulation of an RNA virus is an extremely powerful research tool. In the past twenty years, especially since the first infectious clone of a negative-stranded RNA virus was reported in the mid-1990's, the reverse genetics systems have been available for nearly all the major human and animal RNA virus groups. The article reviews the progress of this technology, highlighting the obstacles in the construction of reverse genetics systems for major groups of human as well as animal RNA viruses and how the virologists overcame them. There are mainly four external expression systems for construction of the RNA virus reverse genetics systems basing on the kind of RNA viruses. These systems include in vitro RNA transcripts, RNA polymerase I-driven expression plasmids, RNA polymerase II-driven expression plasmids and modified vaccinia virus/T7 RNA polymerase-driven expression system. In particular, the viral nucleoprotein and polymerase proteins are required to assemble the viral ribonucleoprotein (RNP) complexes for the rescue of the negative-stranded RNA viruses. Relevant topics about the rescue of the typical viruses are discussed, including poliovirus with the de novo synthesis, Coronaviridae with the largest size of genome, Flaviviridae with the instable clones, HCV with the quasispecies nature, nodaviruses with the virus-host interaction, influenza virus with the RNA pol I transcription system, Arenavirdae with the ambisense coding strategies etc.

Research Development of RNA Replicon-based Vaccines

New Generation Self-Replicating RNA Vaccines Derived from Pestivirus Genome

The Reverse Genetics Systems for Human and Animal RNA Viruses

Trans-Amplifying RNA: A Journey from Alphavirus Research to Future Vaccines

Introduction to RNA Vaccines Post COVID-19

RNA: The new revolution in nucleic acid vaccines

In Vitro Evolution of Enhanced RNA Replicons for Immunotherapy

Construction and cellular immune response induction of HA-based alphavirus replicon vaccines against human-avian influenza (H5N1).

Coatsome-replicon vehicles: Self-replicating RNA vaccines against infectious diseases

Comparation of Immune Reaction Efficiency of RNA Replicon Vaccine and DNA Vaccine of HBV in Mice

Development of a Vaccine Vector Based on a Subgenomic Replicon of Porcine Reproductive and Respiratory Syndrome Virus

Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications

Revolutionizing viral disease vaccination: the promising clinical advancements of non-replicating mRNA vaccines

Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses

A new generation of vaccines based on alphavirus self-amplifying RNA

A DNA-based non-infectious replicon system to study SARS-CoV-2 RNA synthesis

Research Progress of Suicidal DNA Vaccine

DNA Vaccine Immunity Mechanism and the Research of Constructing Optimized Plasmids

Advance in Suicidal DNA Vaccine

Vaccines' New Era-RNA Vaccine

RNA-Based Vaccines and Therapeutics Against Intracellular Pathogens